Biotechnology

Genetic Engineering Drug Development Genetics Pharmaceuticals Nanotechnology Vaccine Development Gene Therapy Research and Development Gene Editing Synthetic Biology

AI-Designed 'Super‑Antigen' Vaccine Clears First Human Test

Machine learning produced a conserved antigen delivered as a DNA vaccine via a needle‑free jet to target multiple sarbecoviruses.

Life Biosciences Doses First Patient With Eye Reprogramming Gene Therapy

Sen. Rand Paul Publishes Documents Detailing Fauci’s Longstanding Intel Contacts and Role in Origins Narrative

One‑Of‑A‑Kind Handbag From Claimed Lab‑Grown T. Rex Leather Goes to Auction in Paris

First Patient Dosed in Human Trial for Cell 'Rejuvenation' Therapy

Samsung Becomes Largest Shareholder in Element Biosciences With $175 Million Stake

Scientists Report First Use of Base Editing in Human Embryos

Columbia Scientists Report Precise Base Edits in Early Human Embryos

AI-Designed 'Super‑Antigen' Vaccine Passes Phase I Safety Test

Columbia Team Reports First Precise Base Edits in Human Embryos

U.S. and Japan Commit $1 Billion to Advance Genesis Mission

Redwire Wins ISS Greenhouse Contract as Shares Jump

China Team Performs First Combined Pig Liver and Both Kidneys Transplant Into Human

Sanofi Launches 'Concierge for Field' AI Sales Agent Built on Snowflake

Lilly Secures Global Rights to Hanmi’s Sonefpeglutide

Wearable Ultrasound Patch Tracks Fetuses Continuously in Early Clinical Tests

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

NanoMesh Nanofiber Implant Doubles Survival in Mouse Glioblastoma Models

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

Single Infusion Gene Editing Lowers LDL by Up to 62% in Early Trial